SQL 6.6 (+0%)
US81734C1062Medical Diagnostics & ResearchDiagnostics & Research

SeqLL (SQL) Competitor Comparison

We are evaluating the key criteria listed to compare SeqLL (SQL) against its competitors in the Diagnostics & Research industry.

Performance 10 years - SQL ranking 51 / 58

These are the competitors of SeqLL in the industry Diagnostics & Research ranked by performance 10 years
1. Lantheus Holdings LNTH
1.66K
2. Heska HSKA
1.65K
3. Medpace Holdings MEDP
1.12K
4. RadNet RDNT
851.11
5. IDEXX Laboratories IDXX
681.21
6. Natera NTRA
621.33
7. DexCom DXCM
536.54
8. Mettler-Toledo MTD
472.07
9. Danaher DHR
433.87
10. Icon ICLR
401.35
11. Thermo Fisher Scientific TMO
390.54
12. CareDx CDNA
337.82
13. IQVIA Holdings IQV
307.16
14. Waters WAT
258.35
15. Agilent Technologies A
255.18
16. Exact Sciences EXAS
251.1
17. PerkinElmer PKI
247.07
18. Twist Bioscience TWST
233.38
19. Charles River Laboratories CRL
209.49
20. NeoGenomics NEO
175.49
21. Quest Diagnostics DGX
146.87
22. Laboratory Corp of America Holdings LH
144.07
23. Fulgent Genetics FLGT
126.82
24. Syneos Health SYNH
113.83
25. Qiagen QGEN
85.13
26. Meridian Bioscience VIVO
60.69
27. National Research NRC
48.04
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Neogen NEOG
-2.77
30. Illumina ILMN
-11.88
31. Inotiv NOTV
-12.27
32. Guardant Health GH
-20.14
33. Bioventus BVS
-22.19
34. Olink Holding OLK
-26.82
35. Myriad Genetics MYGN
-29.53
36. Anixa Biosciences ANIX
-33.68
37. Sotera Health SHC
-41.48
38. Sera Prognostics SERA
-51.97
39. Pacific Biosciences of California PACB
-66.47
40. Global Cord Blood CO
-66.57
41. DarioHealth DRIO
-75.47
42. Personalis PSNL
-78.01
43. Enzo Biochem ENZ
-78.08
44. bioAffinity Technologies BIAF
-78.33
45. MaxCyte MXCT
-78.4
46. Co-Diagnostics CODX
-78.67
47. Exagen XGN
-82.14
48. MDxHealth MDXH
-83.54
49. Psychemedics PMD
-83.96
50. Biodesix BDSX
-87.56
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.87
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.67
56. Interpace Biosciences IDXG
-99.13
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.74

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.